OBJECTIVE: Hypercholesterolemia (HC) and hypertension (HT) are both major risk factors for the development and progression of atherosclerotic heart disease, and their co-existence has been associated with an increased incidence of cardiac events in clinical studies. HC and HT are individually associated with abnormal myocardial vascular function, but whether HT exacerbates the HC-induced myocardial vascular dysfunction remains unclear. METHODS: We studied in pigs the effect of renovascular HT superimposed on diet-induced HC (HC+HT) on myocardial perfusion and microvascular permeability in vivo (using electron-beam computed tomography) in response to cardiac challenge (i.v. adenosine and dobutamine). The involvement of systemic and myocardial tissue oxidative stress in vitro was assessed by oxidizability of LDL, levels of endogenous antioxidants, and tissue activities of radical-scavenger systems. RESULTS: While in normal animals myocardial perfusion increased in response to i.v. adenosine (+36+/-13%, P<0.05), in HC and HT alone the increase was blunted. In HC+HT myocardial perfusion response was further attenuated and significantly lower than normal, and myocardial vascular resistance failed to decrease (+7.6+/-8.8 vs. -21.0+/-5.8%, P=0.02 versus normal). HC+HT also showed blunted response to dobutamine, and augmented increases in microvascular permeability in vivo. These functional abnormalities were associated with increased systemic and myocardial tissue oxidative stress compared to HC or HT alone, and a synergistic decrease in endogenous antioxidant defenses in myocardial tissue. Furthermore, chronic antioxidant vitamin supplementation in combined HC and HT improved myocardial vascular responses. CONCLUSION: HT amplifies the HC-induced myocardial microvascular dysfunction in vivo and increased oxidative stress in vitro. These alterations may potentially play a role in the increased incidence of cardiac events observed when HC and HT co-exist.
OBJECTIVE:Hypercholesterolemia (HC) and hypertension (HT) are both major risk factors for the development and progression of atherosclerotic heart disease, and their co-existence has been associated with an increased incidence of cardiac events in clinical studies. HC and HT are individually associated with abnormal myocardial vascular function, but whether HT exacerbates the HC-induced myocardial vascular dysfunction remains unclear. METHODS: We studied in pigs the effect of renovascular HT superimposed on diet-induced HC (HC+HT) on myocardial perfusion and microvascular permeability in vivo (using electron-beam computed tomography) in response to cardiac challenge (i.v. adenosine and dobutamine). The involvement of systemic and myocardial tissue oxidative stress in vitro was assessed by oxidizability of LDL, levels of endogenous antioxidants, and tissue activities of radical-scavenger systems. RESULTS: While in normal animals myocardial perfusion increased in response to i.v. adenosine (+36+/-13%, P<0.05), in HC and HT alone the increase was blunted. In HC+HT myocardial perfusion response was further attenuated and significantly lower than normal, and myocardial vascular resistance failed to decrease (+7.6+/-8.8 vs. -21.0+/-5.8%, P=0.02 versus normal). HC+HT also showed blunted response to dobutamine, and augmented increases in microvascular permeability in vivo. These functional abnormalities were associated with increased systemic and myocardial tissue oxidative stress compared to HC or HT alone, and a synergistic decrease in endogenous antioxidant defenses in myocardial tissue. Furthermore, chronic antioxidant vitamin supplementation in combined HC and HT improved myocardial vascular responses. CONCLUSION: HT amplifies the HC-induced myocardial microvascular dysfunction in vivo and increased oxidative stress in vitro. These alterations may potentially play a role in the increased incidence of cardiac events observed when HC and HT co-exist.
Authors: Martin Rodriguez-Porcel; Xiang-Yang Zhu; Alejandro R Chade; Beatriz Amores-Arriaga; Noel M Caplice; Erik L Ritman; Amir Lerman; Lilach O Lerman Journal: Am J Physiol Heart Circ Physiol Date: 2005-10-07 Impact factor: 4.733
Authors: Andreas Krebs; Arno Schmidt-Trucksäss; Janine Alt; Jürgen Doerfer; Kristin Krebs; Karl Winkler; Karl Otfried Schwab Journal: Pediatr Cardiol Date: 2009-11 Impact factor: 1.655
Authors: Victor H Urbieta-Caceres; Xiang-Yang Zhu; Kyra L Jordan; Hui Tang; Kyle Textor; Amir Lerman; Lilach O Lerman Journal: Atherosclerosis Date: 2011-10-12 Impact factor: 5.162
Authors: Victor H Urbieta-Caceres; Xiang-Yang Zhu; Matthew E Gibson; Frederic D Favreau; Kyra Jordan; Amir Lerman; Lilach O Lerman Journal: Am J Hypertens Date: 2011-01-13 Impact factor: 2.689
Authors: Alfonso Eirin; Barbara J Williams; Behzad Ebrahimi; Xin Zhang; John A Crane; Amir Lerman; Stephen C Textor; Lilach O Lerman Journal: J Hypertens Date: 2014-01 Impact factor: 4.844
Authors: Jing Lin; Xiangyang Zhu; Alejandro R Chade; Kyra L Jordan; Ronit Lavi; Elena Daghini; Matthew E Gibson; Angelo Guglielmotti; Amir Lerman; Lilach O Lerman Journal: Arterioscler Thromb Vasc Biol Date: 2009-07-23 Impact factor: 8.311